Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heart Test Laboratories, Inc. - Common Stock (NQ: HSCS )

0.0861 -0.0027 (-3.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,145,538
Open 0.0905
Bid (Size) 0.0870 (129)
Ask (Size) 0.0880 (20)
Prev. Close 0.0888
Today's Range 0.0861 - 0.0905
52wk Range 0.0861 - 1.320
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
Patent covers use of AI-ECG for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart disease 
From Heart Test Laboratories, Inc.
Via GlobeNewswire

Performance

YTD
-48.50%
-48.50%
1 Month
-20.43%
-20.43%
3 Month
-33.77%
-33.77%
6 Month
-46.52%
-46.52%
1 Year
-90.22%
-90.22%

More News

Read More
HeartSciences to Present at the LD Micro Invitational XIV Conference
From Heart Test Laboratories, Inc.
Via GlobeNewswire
Recap: Heart Test Laboratories Q3 Earnings
Via Benzinga
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
From Heart Test Laboratories, Inc.
Via GlobeNewswire
HSCS Stock Earnings: Heart Test Laboratories Beats EPS for Q3 2024
Via InvestorPlace
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
From Heart Test Laboratories, Inc.
Via GlobeNewswire
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
From Heart Test Laboratories, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Is Zillow (Z) Stock on the Brink of Death? This Short Seller Thinks So.
Via InvestorPlace
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow Jumps 200 Points; Abercrombie & Fitch Posts Upbeat Profit
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Heart Test Laboratories (HSCS) Stock Down 21% Today?
Via InvestorPlace
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology
From Heart Test Laboratories, Inc.
Via GlobeNewswire
Why CrowdStrike Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
HeartSciences Adds Key Advisor to its Scientific Advisory Board
From Heart Test Laboratories, Inc.
Via GlobeNewswire
HeartSciences Expands its Scientific Advisory Board
From Heart Test Laboratories, Inc.
Via GlobeNewswire
HeartSciences Appoints New Scientific Advisory Board Member
From Heart Test Laboratories, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting
From Heart Test Laboratories, Inc.
Via GlobeNewswire
Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.